» Articles » PMID: 31429206

Research Progress of Vagus Nerve Stimulation in the Treatment of Epilepsy

Overview
Specialties Neurology
Pharmacology
Date 2019 Aug 21
PMID 31429206
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The International League Against Epilepsy (ILAE) defined drug-resistant epilepsy (DRE) that epilepsy seizure symptoms cannot be controlled with two well-tolerated and appropriately chosen antiepileptic drugs, whether they are given as monotherapy or in combination. According to the WHO reports, there is about 30%-40% of epilepsy patients belong to DRE. These patients need some treatments other than drugs, such as epilepsy surgery, and neuromodulation treatment. Traditional surgical approaches may be limited by the patient's clinical status, pathological tissue location, or overall prognosis. Thus, neuromodulation is an alternative choice to control their symptoms. Vagus nerve stimulation (VNS) is one of the neuromodulation methods clinically, which have been approved by the Food and Drug Administration (FDA). In this review, we systematically describe the clinical application, clinical effects, possible antiepileptic mechanisms, and future research directions of VNS for epilepsy.

Citing Articles

Vagus nerve stimulation for epilepsy: A narrative review of factors predictive of response.

Clifford H, Paranathala M, Wang Y, Thomas R, Costa T, Duncan J Epilepsia. 2024; 65(12):3441-3456.

PMID: 39412361 PMC: 11647441. DOI: 10.1111/epi.18153.


Neuroprotective Efficacy and Complementary Treatment with Medicinal Herbs: A Comprehensive Review of Recent Therapeutic Approaches in Epilepsy Management.

Anand A, Shrivastava A, Singh K, Barik R, Gayakwad D, S J CNS Neurol Disord Drug Targets. 2024; 24(1):60-73.

PMID: 39069797 DOI: 10.2174/0118715273332140240724093837.


Effect of Vagus Nerve Stimulation on the GASH/Sal Audiogenic-Seizure-Prone Hamster.

Goncalves-Sanchez J, Sancho C, Lopez D, Castellano O, Garcia-Cenador B, Servilha-Menezes G Int J Mol Sci. 2024; 25(1).

PMID: 38203262 PMC: 10778912. DOI: 10.3390/ijms25010091.


Intermittent hypoxia: linkage between OSAS and epilepsy.

Ma Y, Wu Q Front Pharmacol. 2023; 14:1230313.

PMID: 38074156 PMC: 10701596. DOI: 10.3389/fphar.2023.1230313.


A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management.

Ghosh S, Sinha J, Ghosh S, Sharma H, Bhaskar R, Narayanan K Brain Sci. 2023; 13(9).

PMID: 37759906 PMC: 10527076. DOI: 10.3390/brainsci13091305.


References
1.
Henry T, Votaw J, Pennell P, Epstein C, Bakay R, Faber T . Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology. 1999; 52(6):1166-73. DOI: 10.1212/wnl.52.6.1166. View

2.
Chrastina J, Novak Z, Zeman T, Kocvarova J, Pail M, Dolezalova I . Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study. Seizure. 2018; 59:41-47. DOI: 10.1016/j.seizure.2018.04.022. View

3.
George R, Salinsky M, Kuzniecky R, Rosenfeld W, Bergen D, Tarver W . Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia. 1994; 35(3):637-43. DOI: 10.1111/j.1528-1157.1994.tb02484.x. View

4.
Arya R, Greiner H, Lewis A, Mangano F, Gonsalves C, Holland K . Vagus nerve stimulation for medically refractory absence epilepsy. Seizure. 2013; 22(4):267-70. DOI: 10.1016/j.seizure.2013.01.008. View

5.
Conway C, Udaiyar A, Schachter S . Neurostimulation for depression in epilepsy. Epilepsy Behav. 2018; 88S:25-32. DOI: 10.1016/j.yebeh.2018.06.007. View